DE602004021395D1 - Verfahren zur behandlung von hepatozellulärem karzinom - Google Patents

Verfahren zur behandlung von hepatozellulärem karzinom

Info

Publication number
DE602004021395D1
DE602004021395D1 DE602004021395T DE602004021395T DE602004021395D1 DE 602004021395 D1 DE602004021395 D1 DE 602004021395D1 DE 602004021395 T DE602004021395 T DE 602004021395T DE 602004021395 T DE602004021395 T DE 602004021395T DE 602004021395 D1 DE602004021395 D1 DE 602004021395D1
Authority
DE
Germany
Prior art keywords
zvegf3
hepatocellular carcinoma
mammal
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004021395T
Other languages
German (de)
English (en)
Inventor
Thomas E Palmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of DE602004021395D1 publication Critical patent/DE602004021395D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE602004021395T 2003-07-25 2004-07-09 Verfahren zur behandlung von hepatozellulärem karzinom Expired - Lifetime DE602004021395D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49004703P 2003-07-25 2003-07-25
PCT/US2004/021835 WO2005011742A1 (en) 2003-07-25 2004-07-09 Method of treating hepatocellular carcinoma

Publications (1)

Publication Number Publication Date
DE602004021395D1 true DE602004021395D1 (de) 2009-07-16

Family

ID=34115347

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004021395T Expired - Lifetime DE602004021395D1 (de) 2003-07-25 2004-07-09 Verfahren zur behandlung von hepatozellulärem karzinom

Country Status (9)

Country Link
US (4) US20050191304A1 (https=)
EP (1) EP1660135B1 (https=)
JP (1) JP4709145B2 (https=)
AT (1) ATE432716T1 (https=)
CA (1) CA2529798C (https=)
DE (1) DE602004021395D1 (https=)
DK (1) DK1660135T3 (https=)
ES (1) ES2326978T3 (https=)
WO (1) WO2005011742A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6893637B1 (en) * 1999-10-21 2005-05-17 Zymogenetics, Inc. Method of treating fibrosis
RU2014140116A (ru) * 2012-04-24 2016-06-10 Тромбодженикс Н.В. Антитела против pdgf-c

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1137773T3 (da) * 1998-12-07 2008-12-08 Zymogenetics Inc Væsktfaktorhomolog ZVEGF3
US6432673B1 (en) * 1998-12-07 2002-08-13 Zymogenetics, Inc. Growth factor homolog ZVEGF3
US6893637B1 (en) * 1999-10-21 2005-05-17 Zymogenetics, Inc. Method of treating fibrosis

Also Published As

Publication number Publication date
EP1660135B1 (en) 2009-06-03
ATE432716T1 (de) 2009-06-15
US20090028865A1 (en) 2009-01-29
JP2006528663A (ja) 2006-12-21
ES2326978T3 (es) 2009-10-22
CA2529798A1 (en) 2005-02-10
JP4709145B2 (ja) 2011-06-22
EP1660135A1 (en) 2006-05-31
WO2005011742A1 (en) 2005-02-10
CA2529798C (en) 2014-09-16
US20110052588A1 (en) 2011-03-03
US20070054858A1 (en) 2007-03-08
US20050191304A1 (en) 2005-09-01
DK1660135T3 (da) 2009-09-07

Similar Documents

Publication Publication Date Title
DK1638586T3 (da) Synergistisk sammensætning til behandling af diabetes mellitus
WO2005107726A3 (en) Method for the treatment of back pain
IL267381A (en) A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders
ATE314062T1 (de) Zusammensetzungen zur abgabe von cortisolantagonisten
DE60234183D1 (de) Verwendung von methylnaltrexon zur behandlung von immunsuppression
DE69925024D1 (de) Verwendung von eph-rezeptor-antagonisten und agonisten zur behandlung von vaskulären krankheiten
IL178175A0 (en) Tamper resistant dosage form comprising an adsorbent and an adverse agent
EP1140840A4 (en) -G (V) -CARBOXYARYL SUBSTITUTED DIPHENYL UREASINE AS RAF KINASE INHIBITORS
BRPI0519124A2 (pt) composto, mÉtodo para tratar, prevenir ou melhorar obesidade e doenÇas relacionadas e/ou sintomas das mesmas, composiÇço farmacÊutica, uso de composto, e, combinaÇço
ATE364595T1 (de) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
DE602005026169D1 (de) Tetrahydroisochinolinverbindungen zur behandlung von zns-erkrankungen
ATE394104T1 (de) Adenosin a2a rezeptor-antagonisten zur behandlung und vorbeugung von leberfibrose, zirrhose und fettleber
ATE465735T1 (de) Verwendung einer kombination von morphin und mindestens einem opiatantagonisten zur behandlung von opiatabhängigkeit und zur verhinderung des nicht-oralen opiatmissbrauchs bei opiatsüchtigen
JP2003528919A5 (https=)
WO2003051290A3 (en) Treating b-cell mediated diseases by modulating dr6 activity
DE602004021395D1 (de) Verfahren zur behandlung von hepatozellulärem karzinom
EA200700403A1 (ru) ТРИЦИКЛИЧЕСКИЕ δ-ОПИОИДНЫЕ МОДУЛЯТОРЫ
EA200800766A1 (ru) Ингибиторы pi3k для лечения эндометриоза
NO20051261L (no) Morfin-6-glukuronidsalt
WO2006041769A3 (en) Methods for the treatment of substance abuse and addiction
ATE454153T1 (de) 5-ht4 antagonisten zur behandlung von herzversagen
WO2004039961A3 (en) Trefoil domain-containing polypeptides and uses thereof
NO20053189L (no) HVC-kombinasjonsterapi.
WO2007062048A3 (en) Role of proteoglycans in drug dependence
WO2005037318A3 (en) Treatment of arthritic conditions, chronic inflammation or pain

Legal Events

Date Code Title Description
8364 No opposition during term of opposition